TAP-144-SR(6M)
TAP-144-SR(6M)IP/CPH-202
Phase 3 small_molecule completed
Quick answer
TAP-144-SR(6M) for Premenopausal Breast Cancer is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Premenopausal Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed